Cycurion, Inc.
For the period ended Dec 31, 2025. Filed Mar 31, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 31, 2026
CYCU$2.470.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
CONSOLIDATED STATEMENTS OF CASH FLOWS
| For the Year Ended December 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Cash flows from operating activities: | ||
| Net (loss)/income | $(24,059,084) | $1,229,601 |
| Adjustments to reconcile net (loss)/income to net cash used in operating activities: | ||
| Stock-based compensation | 3,898,867 | 10,000 |
| Stock-based compensation - business combination related | 9,521,734 | - |
| Amortization of debt discount | 242,095 | 6,566 |
| Depreciation of property and equipment | 20,321 | 13,341 |
| Amortization of software development costs | 25,000 | 16,667 |
| Gain on debt settlement, net | (1,221,635) | - |
| Finance expense | 100,000 | - |
| Changes in assets and liabilities: | ||
| Accounts receivable, net and other receivables | 363,405 | (3,492,651) |
| Prepaid expenses and other current assets | 39,330 | (43,448) |
| Accounts payable and accrued liabilities | (836,585) | 562,946 |
| Accrued compensation and benefits | (59,859) | 345,908 |
| Accrued interest payable | (119,946) | (20,211) |
| Net cash used in operating activities | (12,086,357) | (1,371,281) |
| Cash flows from investing activities: | ||
| Cash acquired on business combination | 34,983 | 2,048 |
| Issuance of promissory notes | - | (439,114) |
| Capitalized software development costs | (455,000) | (448,000) |
| Cash withdrawn from Trust Account in connection with redemption | 1,001,216 | - |
| Release of Trust Account to Company's bank account | 833,324 | - |
| Net cash provided by/(used in) investing activities | 1,414,523 | (885,066) |
| Cash flows from financing activities: | ||
| Proceeds from exercise of warrants | 3,664,871 | - |
| Redemption of common stock subject to redemption | (1,001,216) | - |
| Proceeds from private placement | 4,780,021 | 1,000,000 |
| Proceeds from capital raise | 6,983,688 | - |
| Proceeds from revolving line of credit | - | 252,314 |
| Repayments of revolving line of credit | (315,671) | - |
| Proceeds from bank borrowings | - | 31,954 |
| Repayment of bank borrowings | (775,192) | - |
| Repayment of loans payable | (210,843) | - |
| Proceeds from convertible notes payable | 2,376,500 | - |
| Proceeds from notes payable | 513,200 | 390,000 |
| Proceeds from notes payable - related parties | - | 15,000 |
| Repayments of notes payable - related parties | (27,500) | - |
| Repayments of notes payable | (101,579) | - |
| Net cash provided by financing activities | 15,886,279 | 1,689,268 |
| Net increase/(decrease) in cash and cash equivalents | 5,214,445 | (567,079) |
| Cash and cash equivalents, beginning of year | 40,790 | 607,869 |
| Cash and cash equivalents, end of year | $5,255,235 | $40,790 |
| See accompanying notes to consolidated financial statements | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.